Stephens Seth
Texas Tech University Health Sciences Center, Anita Thigpen Perry School of Nursing, 3601 4th Street, Stop 6264, Lubbock, TX 79430-6264, USA.
Crit Care Nurs Clin North Am. 2010 Jun;22(2):209-15. doi: 10.1016/j.ccell.2010.03.013.
This article evaluates the current literature concerning the use of perioperative beta-blockade to reduce cardiac events in hopes that it may provide direction to clinicians or demonstrate gaps in medical knowledge, thus revealing areas suitable for future study. The current standard of practice for the use of perioperative beta-blockade in preoperative patients is outlined in the American College of Cardiology (ACC) and American Heart Association (AHA) guidelines. Findings differ as to the risk and benefit of using beta-blockers perioperatively to reduce cardiac events. Further research is needed to support the ACC/AHA recommendations. It is essential that the decision to use beta-blockade be made on a case-by-case basis with adequate risk stratification as part of the criteria.
本文评估了有关围手术期使用β受体阻滞剂以减少心脏事件的当前文献，希望能为临床医生提供指导，或揭示医学知识方面的差距，从而找出适合未来研究的领域。美国心脏病学会（ACC）和美国心脏协会（AHA）的指南概述了术前患者围手术期使用β受体阻滞剂的当前实践标准。关于围手术期使用β受体阻滞剂减少心脏事件的风险和益处，研究结果存在差异。需要进一步的研究来支持ACC/AHA的建议。至关重要的是，使用β受体阻滞剂的决定应根据具体情况做出，并将充分的风险分层作为标准的一部分。
